Version history

{
  "content_md": "\n\n# ALZHEIMER\n\n## Summary\n\nALZHEIMER is a gene associated with Alzheimer's disease pathology and neurodegenerative processes. It plays a significant role in disease activation, neuroinflammation modulation, and cellular senescence pathways. The gene has been identified as a therapeutic target in multiple neurodegenerative disease contexts and serves as a biomarker for Alzheimer's disease.\n\n---\n\n## Biological Function\n\nALZHEIMER participates in multiple biological pathways relevant to neurodegeneration:\n\n- **Inflammation Regulation**: Inhibits both general Inflammation and Neuroinflammation (strength: 1.00)\n- **Senescence Association**: Associated with cellular Senescence processes (strength: 1.00)\n- **Aging Modulation**: Exhibits inhibitory effects on Aging (strength: 1.00)\n- **Pathway Activation**: Activates the Complement pathway (strength: 1.00)\n- **Neurodegeneration Activation**: Activates both NEURODEGENERATIVE DISEASES and NEURODEGENERATIVE DISORDERS genes (strength: 1.00)\n\n---\n\n## Key Relationships\n\n### Outgoing Relationships (ALZHEIMER → others)\n\n| Relationship | Target | Strength |\n|--------------|--------|----------|\n| activates | Alzheimer (disease) | 1.00 |\n| biomarker_for | Alzheimer (disease) | 1.00 |\n| interacts_with | Alzheimer (disease) | 1.00 |\n| activates | NEURODEGENERATIVE DISEASES (gene) | 1.00 |\n| activates | NEURODEGENERATIVE DISORDERS (gene) | 1.00 |\n| activates | Complement (pathway) | 1.00 |\n| inhibits | Neuroinflammation (disease) | 1.00 |\n| inhibits | Inflammation (disease) | 1.00 |\n| inhibits | Aging (disease) | 1.00 |\n| associated_with | Senescence (disease) | 1.00 |\n\n### Incoming Relationships (others → ALZHEIMER)\n\n| Relationship | Source Gene | Strength |\n|--------------|-------------|----------|\n| therapeutic_target | DEMENTIA | 1.00 |\n| therapeutic_target | TAU | 1.00 |\n| therapeutic_target | NEURODEGENERATION | 1.00 |\n| activates | APP/PS1 | 1.00 |\n| activates | TAU | 1.00 |\n| activates | TREM2 | 1.00 |\n| activates | OXIDATIVE STRESS | 1.00 |\n| biomarker_for | NEURODEGENERATION | 1.00 |\n| protects_against | NEURODEGENERATION | 1.00 |\n| inhibits | APOPTOSIS | 1.00 |\n\n---\n\n## Research Context\n\n### Hypotheses Involving ALZHEIMER\n\n**1. Closed-loop transcranial focused ultrasound with 40Hz gamma entrainment to restore hippocampal-cortical connectivity in early MCI** (Score: 1.00)\n- Explores PVALB modulation to restore neural connectivity in early mild cognitive impairment\n\n**2. Metabolic Reprogramming to Reverse Senescence** (Score: 1.00)\n- Investigates metabolic mechanisms to reverse cellular senescence in neurodegeneration\n\n**3. TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration** (Score: 0.99)\n- Examines TREM2-mediated immune cell interactions in neurodegenerative contexts\n\n**4. TREM2-Dependent Microglial Senescence Transition** (Score: 0.95)\n- Studies microglial senescence pathways controlled by TREM2\n\n**5. Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons** (Score: 0.95)\n- Targets specific interneuron populations to restore hippocampal gamma oscillations in Alzheimer's disease\n\n### SciDEX Analyses\n\nNo SciDEX analyses have been documented for this entity.\n\n---\n\n## Disease Associations\n\n### Primary Disease: Alzheimer's Disease\n- ALZHEIMER **activates** Alzheimer's disease pathology\n- Serves as a **biomarker** for disease detection\n- **Interacts_with** the disease through multiple pathways\n\n### Related Disease Processes\n- **Neuroinflammation**: Inhibited by ALZHEIMER, suggesting anti-inflammatory regulatory function\n- **Senescence**: Associated with cellular aging processes\n- **Aging**: Inhibited by ALZHEIMER activity\n- **Complement Pathway**: Activated by ALZHEIMER, indicating involvement in immune-mediated mechanisms\n\n---\n\n## References\n\n1. PMID 34553778: \"Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease.\"\n\n2. PMID 32781522: \"Involvement of p38 MAPK in Synaptic Function and Dysfunction.\"\n\n3. PMID 39307583: \"Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine.\"\n\n4. PMID 36843263: \"Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease.\"\n\n5. PMID 28163132: \"Aging leads to altered microglial function that reduces brain resiliency increasing vulnerability to neurodegenerative diseases.\"",
  "entity_type": "gene",
  "kg_node_id": "alzheimer",
  "refs_json": {
    "pubmed28163132": {
      "pmid": "28163132",
      "year": 0,
      "title": "",
      "authors": "[]",
      "journal": "",
      "strength": 0.5
    },
    "pubmed32781522": {
      "pmid": "32781522",
      "year": 0,
      "title": "",
      "authors": "[]",
      "journal": "",
      "strength": 0.5
    },
    "pubmed34553778": {
      "pmid": "34553778",
      "year": 0,
      "title": "",
      "authors": "[]",
      "journal": "",
      "strength": 0.5
    },
    "pubmed36843263": {
      "pmid": "36843263",
      "year": 0,
      "title": "",
      "authors": "[]",
      "journal": "",
      "strength": 0.5
    },
    "pubmed39307583": {
      "pmid": "39307583",
      "year": 0,
      "title": "",
      "authors": "[]",
      "journal": "",
      "strength": 0.5
    }
  },
  "epistemic_status": "speculative",
  "word_count": 579,
  "source_repo": "scidex_generated"
}